AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DIHYDROARTEMISININE / PHOSPHATE DE PIPERAQUINE

10 registrations across 1 African market— 10 active

Markets with DIHYDROARTEMISININE / PHOSPHATE DE PIPERAQUINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
PALUCARE
comprimé / 40 mg / 320 mg
🇸🇳SenegalGENERIC HEALTH CARE PVT LTDactive
PALUCARE
comprimé / 20 mg / 160 mg
🇸🇳SenegalGENERIC HEALTH CARE PVT LTDactive
DARTE-Q
granulé en sachet / 120 mg / 15 mg
🇸🇳SenegalGOSUN PHARMA CORPactive
DARTE-Q
gélule / 40 mg/320 mg
🇸🇳SenegalGOSUN PHARMA CORPactive
MALWOOD P
comprimé / 40 mg / 320 mg
🇸🇳SenegalHALEWOOD LABORATORIES PVT. LTD. 319active
PLASMOCUR
comprimé pelliculé / 320 mg / 40 mg
🇸🇳SenegalEXPHAactive
PLASMOCUR
comprimé pelliculé sécable / 640 mg / 80 mg
🇸🇳SenegalEXPHA LID ZEINENWEGactive
PLASMOCUR
comprime / 80 mg / 640 mg
🇸🇳SenegalEXPHAactive
MALACUR
comprimé / 40 mg/320 mg
🇸🇳SenegalSALVAT GALLactive
PLASMOCUR
comprime / 80 mg / 640 mg
🇸🇳SenegalEXPHAactive

DIHYDROARTEMISININE / PHOSPHATE DE PIPERAQUINE in Africa — Regulatory Overview

DIHYDROARTEMISININE / PHOSPHATE DE PIPERAQUINE is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.